Company Focus

Eli Lilly & Company

Latest Eli Lilly & Company News

Lilly and Laekna team up on novel obesity drugs
Biotechnology
Eli Lilly is not resting on its laurels when it comes to the fast-growing field of obesity treatments, an area in which it is already a leader.   21 November 2024


Latest News & Features of interest to Eli Lilly & Company

Latest In Brief for Eli Lilly & Company

Biotechnology
The Federal Commission for the Protection Against Sanitary Risk (COFEPRIS) in Mexico has approved humanized anti-soluble aggregated amyloid-beta (Aβ) monoclonal antibody Leqembi (lecanemab) for the treatment of early Alzheimer’s disease (AD).   5 December 2024

Latest Related Ones To Watch News

Venture capital firm BC Partners has entered into an agreement under which the private equity business at Goldman Sachs Alternatives will acquire a majority stake in Netherlands-based Synthon, from funds advised by BC Partners.   17 December 2024

More in M&A >


Related Ones to Watch Companies

Reset all filters
Refine Search